Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.52
-0.17 (-2.99%)
At close: Jul 3, 2025, 1:00 PM
5.50
-0.02 (-0.36%)
After-hours: Jul 3, 2025, 3:25 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $260.71 million as of July 3, 2025. Its market cap has decreased by -70.56% in one year.
Market Cap
260.71M
Enterprise Value
124.24M
1-Year Change
-70.56%
Ranking
Category
Stock Price
$5.52
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $260.71M, a decrease of -51.57%. That is a compound annual growth rate of -13.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 260.71M | -19.74% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |